ArticlePloS one2016

Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.

Wei-Chun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.